Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,897 signal articles · 138 in last 24h · 157,635 total before filter · latest 8h ago
138last 24h
824last 7d
129● bullish (7d)
77● bearish (7d)
214publishers
AllMacro186Earnings137M&A96Regulatory15Product16Analyst24
✕ clear all filtersticker: NVDASentiment:bullishneutralbearish✓ showing all (incl. clickbait)
3 Not-So-Obvious AI Stocks to Buy in July
24/7 Wall St.71d agobullish
3 Not-So-Obvious AI Stocks to Buy in July

Everyone already owns NVIDIA, Microsoft, and Alphabet, but the real AI infrastructure buildout is quietly funneling billions into a different layer of the stack. Three under-the-radar names are converting that spending into hard revenue growth right now.

Will GM or 3M Crush Earnings? Wall Street Favors This One
24/7 Wall St.71d agoneutral
Will GM or 3M Crush Earnings? Wall Street Favors This One

GM and 3M both report Q2 2026 earnings Tuesday morning, and both stocks carry four straight quarters of EPS beats. But analyst ratings, sentiment scores, and prediction markets are telling very different stories about which name deserves your attention right now.

Bristol Myers buys Nvidia's latest AI computing system for drug research
Reuters71d agobullish
Bristol Myers buys Nvidia's latest AI computing system for drug research

Bristol Myers Squibb said on Monday it is buying the latest-generation computing system from chip company Nvidia ‌to support its use of artificial intelligence across its drug discovery and development ‌operations. The drugmaker said it will be the first life sciences company to buy an Nvidia DGX SuperPOD ​based on its Vera Rubin systems. The chipmaker unveiled its Vera Rubin architecture earlier this year as the successor to its current generation of AI computing systems.